Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prime "Rib" Time: Continuous Intercostal Nerve Blockade for Rib Fractures
NCT02604589Terminated
- Start
- Mar 2016
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of bupivacaine in rib fracture (3 arms). Primary endpoint: Narcotic Use. Started Mar 2016; status: terminated.
02
Drugs
bupivacaine
03
Conditions
rib fracture
Beyond the preview
Go deeper on NCT02604589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02604589.